Lupus Research Alliance Honors the Life of Beloved Board Member William J. Mulvihill
The Lupus Research Alliance deeply mourns the loss of William “Bill” J. Mulvihill, a dedicated member of the organization’s...
Search Results
You searched for: lupus nephritis
Results found: 1166
Neovacs Announces the Results of its Phase IIb Study for Ifnalpha Kinoid in the Treatment of Lupus Which Allows to Proceed With the Clinical Development into Phase III
July 3, 2018
Neovacs announced the results of its Phase IIb clinical trial of the investigational agent IFNalpha Kinoid in...
Community Spotlight: How Peer Educator Martha Chisholm is Living – And Advocating For – Life Beyond Lupus
Martha Chisholm spent years seeking answers. Now, as a patient advocate, she’s helping others find theirs. What was once...
Lupus Research Alliance Invites Communities to Walk with Us to Cure Lupus Fall Season
Thousands of dedicated lupus champions will kick off the Lupus Research Alliance Fall Walk with Us to Cure Lupus...
Lupus Research Turns Immune System Enemies into Friends
Jan. 17, 2018
Lupus Research Turns Immune System Enemies into Friends
With support from a Lupus Research Alliance Novel Research Grant,...
2017 Lupus Insight Prize Winner
2017 Lupus Insight Prize Winner
Shares Her Insights About Childhood Lupus
Dec. 20, 2017. In piecing together the many complex and...
Highlights from ACR Convergence 2024: Groundbreaking LRA-Funded Research and Innovative Therapies
The Lupus Research Alliance (LRA) is proud to showcase the groundbreaking work of its funded researchers presented at the...
LRA Joins NIAMS Coalition in Supporting Congressional Act Promoting Clinical Trial Diversity
The Lupus Research Alliance and Lupus Therapeutics support diversity in clinical trials to ensure that populations that test potential...
Join our 2026 Virtual Advocacy Day to Support Lupus Research
This year, together with advocates like you, we convinced Congress to restore millions in funding for lupus research. We...
BLyS-specific Inhibitors
Belimumab, a type of agent referred to as a B-lymphocyte stimulator (BLyS) protein inhibitor, was approved by the U.S....
New Jersey Walk with Us to Cure Lupus
The 2020 New Jersey Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance's national...
Lupus Industry Council Accomplishments
Return to Research Partners
Drivers of Response and Non-response for SRI-4 and BICLA in Systemic Lupus Erythematosus (SLE) Clinical Trials
Working...